SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Aurora Biosciences (ABSC)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: jay silberman who wrote ()2/7/2000 11:08:00 AM
From: sim1   of 359
 
Aurora to sell 1.8 mln shares in private placement

SAN DIEGO, Feb 7 (Reuters) - Aurora Biosciences Corp. (NASDAQ: ABSC) said on Monday it would sell 1.8 million common shares for about $75 million, or $42 a share, in a private placement with selected institutional and other investors.

The company said it would use the proceeds for development and acquisition of new technologies, particularly in genomics, the study of the structure and function of a gene, and drug discovery.

The proceeds would also be used for commercial development, working capital and other general corporate purposes, the company said.

Aurora's shares closed at 48-1/4 on Friday, near its 52-week high of 51. The shares had been as low as 10-1/2 in mid-December.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext